Alejandro Ruiz-Picazo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Magnetic Resonance

Lower Urinary Tract Symptoms

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Claudia Miranda, Alejandro Ruiz-Picazo, Paula Pomares, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez, Alex Avdeef, Miguel Ángel Cabrera-Pérez
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics 14 (1) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Mercedes Prieto-Escolar, Juan José Torrado, Covadonga Álvarez, Alejandro Ruiz-Picazo, Marta Simón-Vázquez, Carlos Govantes, Jesús Frías, Alfredo Garcia-Arieta, Isabel González-Álvarez, Marival Bermejo
One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products. Pharmaceutics 13 (5) (2021)